149 related articles for article (PubMed ID: 27158894)
1. Biphasic and Stage-Associated Expression of CPEB4 in Hepatocellular Carcinoma.
Tsai LY; Chang YW; Lee MC; Chang YC; Hwang PI; Huang YS; Cheng CF
PLoS One; 2016; 11(5):e0155025. PubMed ID: 27158894
[TBL] [Abstract][Full Text] [Related]
2. CPEB4 immunohistochemical expression is associated to prognosis in stage IV colorectal carcinoma.
Cortés-Guiral D; Pastor-Iodate C; Díaz Del Arco C; Del Puerto-Nevado L; Fernández-Aceñero MJ
Pathol Res Pract; 2017 Jun; 213(6):639-642. PubMed ID: 28551384
[TBL] [Abstract][Full Text] [Related]
3. Sequential Functions of CPEB1 and CPEB4 Regulate Pathologic Expression of Vascular Endothelial Growth Factor and Angiogenesis in Chronic Liver Disease.
Calderone V; Gallego J; Fernandez-Miranda G; Garcia-Pras E; Maillo C; Berzigotti A; Mejias M; Bava FA; Angulo-Urarte A; Graupera M; Navarro P; Bosch J; Fernandez M; Mendez R
Gastroenterology; 2016 Apr; 150(4):982-97.e30. PubMed ID: 26627607
[TBL] [Abstract][Full Text] [Related]
4. Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.
Qiu H; Zhang X; Ni W; Shi W; Fan H; Xu J; Chen Y; Ni R; Tao T
Dig Dis Sci; 2016 Mar; 61(3):795-805. PubMed ID: 26553251
[TBL] [Abstract][Full Text] [Related]
5. The tumor suppressive miR-26a regulation of FBXO11 inhibits proliferation, migration and invasion of hepatocellular carcinoma cells.
Ma Y; Deng F; Li P; Chen G; Tao Y; Wang H
Biomed Pharmacother; 2018 May; 101():648-655. PubMed ID: 29518611
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic polyadenylation element-binding protein 4 is highly expressed in human glioma.
Hu H; Cong L; Liang C; Yang L; Guo E; Song J; Liu L; Lu S; Guo C; Wu Z; Ma S; Zhao Z; Wang L; Jiao B
Neuroreport; 2016 May; 27(8):593-9. PubMed ID: 27096214
[TBL] [Abstract][Full Text] [Related]
7. MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway.
Liu FY; Zhou SJ; Deng YL; Zhang ZY; Zhang EL; Wu ZB; Huang ZY; Chen XP
Cell Death Dis; 2015 Mar; 6(3):e1670. PubMed ID: 25741595
[TBL] [Abstract][Full Text] [Related]
8. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway.
Wang F; Ying HQ; He BS; Pan YQ; Deng QW; Sun HL; Chen J; Liu X; Wang SK
Oncotarget; 2015 Apr; 6(10):7899-917. PubMed ID: 25760077
[TBL] [Abstract][Full Text] [Related]
9. High expression of MAGE-A9 contributes to stemness and malignancy of human hepatocellular carcinoma.
Wei Y; Wang Y; Gong J; Rao L; Wu Z; Nie T; Shi D; Zhang L
Int J Oncol; 2018 Jan; 52(1):219-230. PubMed ID: 29138811
[TBL] [Abstract][Full Text] [Related]
10. Waltonitone inhibits proliferation of hepatoma cells and tumorigenesis via FXR-miR-22-CCNA2 signaling pathway.
Yang F; Gong J; Wang G; Chen P; Yang L; Wang Z
Oncotarget; 2016 Nov; 7(46):75165-75175. PubMed ID: 27738335
[TBL] [Abstract][Full Text] [Related]
11. Bromodomain-containing protein 7 (BRD7) as a potential tumor suppressor in hepatocellular carcinoma.
Chen CL; Wang Y; Pan QZ; Tang Y; Wang QJ; Pan K; Huang LX; He J; Zhao JJ; Jiang SS; Zhang XF; Zhang HX; Zhou ZQ; Weng de S; Xia JC
Oncotarget; 2016 Mar; 7(13):16248-61. PubMed ID: 26919247
[TBL] [Abstract][Full Text] [Related]
12. Downregulated cytoplasmic polyadenylation element-binding protein-4 is associated with the carcinogenesis of head and neck squamous cell carcinoma.
Zeng M; Li F; Wang L; Chen C; Huang X; Wu X; She W; Zhou L; Tao Z
Oncol Lett; 2018 Mar; 15(3):3226-3232. PubMed ID: 29435062
[TBL] [Abstract][Full Text] [Related]
13. High expression of cytoplasmic polyadenylation element-binding protein 4 correlates with poor prognosis of patients with colorectal cancer.
He X; Lin X; Cai M; Fan D; Chen X; Wang L; Wu X; Lan P; Wang J
Virchows Arch; 2017 Jan; 470(1):37-45. PubMed ID: 27771769
[TBL] [Abstract][Full Text] [Related]
14. Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth.
Yang WL; Wei L; Huang WQ; Li R; Shen WY; Liu JY; Xu JM; Li B; Qin Y
Oncol Rep; 2014 May; 31(5):2328-34. PubMed ID: 24676454
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical overexpression of MBNL2 in hepatocellular carcinoma inhibits tumor growth and invasion.
Lee YH; Jhuang YL; Chen YL; Jeng YM; Yuan RH
Oncotarget; 2016 Oct; 7(40):65589-65601. PubMed ID: 27564110
[TBL] [Abstract][Full Text] [Related]
16. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
Yan S; Tang Z; Chen K; Liu Y; Yu G; Chen Q; Dang H; Chen F; Ling J; Zhu L; Huang A; Tang H
J Exp Clin Cancer Res; 2018 Sep; 37(1):214. PubMed ID: 30176933
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA CASC15 is upregulated in hepatocellular carcinoma and facilitates hepatocarcinogenesis.
He T; Zhang L; Kong Y; Huang Y; Zhang Y; Zhou D; Zhou X; Yan Y; Zhang L; Lu S; Zhou J; Wang W
Int J Oncol; 2017 Dec; 51(6):1722-1730. PubMed ID: 29075788
[TBL] [Abstract][Full Text] [Related]
19. Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K/Akt pathway.
Hsieh YH; Hsieh SC; Lee CH; Yang SF; Cheng CW; Tang MJ; Lin CL; Lin CL; Chou RH
Oncotarget; 2015 Oct; 6(33):34859-74. PubMed ID: 26472188
[TBL] [Abstract][Full Text] [Related]
20. Expression of protein TARBP1 in human hepatocellular carcinoma and its prognostic significance.
Ye J; Wang J; Tan L; Yang S; Xu L; Wu X; Deng H; Tan H
Int J Clin Exp Pathol; 2015; 8(8):9089-96. PubMed ID: 26464651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
